CSLLYCsl ADR

$17.12
$0.49
(2.95%)
Today
Updated: 03:59 PM EDT
EarningsAug 17
Mkt Cap$32.8B
Vol420,549.00
News
all
press releases
Should Value Investors Buy CSL Limited (CSLLY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
News Placeholder
More News
News Placeholder
CSLLY vs. ACAD: Which Stock Is the Better Value Option?
CSLLY vs. ACAD: Which Stock Is the Better Value Option?
Zacks
News Placeholder
CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?
CSLLY vs. ACAD: Which Stock Is the Better Value Option?
Zacks
News Placeholder
CSLLY or ARGX: Which Is the Better Value Stock Right Now?
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
Zacks
News Placeholder
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
Zacks
News Placeholder
CSLLY or EXAS: Which Is the Better Value Stock Right Now?
CSLLY vs. EXAS: Which Stock Is the Better Value Option?
Zacks
News Placeholder
CSLLY vs. EXAS: Which Stock Is the Better Value Option?
CSLLY vs. EXAS: Which Stock Is the Better Value Option?
Zacks
News Placeholder
CSL Limited (CSLLY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for CSL Limited (CSLLY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks
News Placeholder
CSLLY or TECH: Which Is the Better Value Stock Right Now?
CSLLY vs. TECH: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Australia’s CSL hits 6-wk high on report of R&D division job cuts
Investing.com-- Shares of Australia’s CSL Ltd (ASX:CSL) climbed over 3% on Tuesday after the Australian Financial Review reported the biotech giant is planning to cut around one-third of its roughly 2,500-strong global R&D workforce.
investing.com
<
1
2
...
>

Advertisement|Remove ads.